• ABOUT US
    ▼
    • Our Vision
    • Leadership Team
  • OUR RESEARCH
    ▼
    • Our Approach
    • Publications
    • Conferences
  • PROGRAMS
    ▼
    • Pipeline
    • VIS649 Sibeprenlimab
    • VIS171
    • VIS513
  • FOR PATIENTS
    ▼
    • Clinical Trials
    • IgA Nephropathy
  • CAREERS
    ▼
    • Open Positions & Benefits
    • Our Culture
    • Co-op program
  • Contact

Visterra

We Bring Better Biologics to Life

  • ABOUT US
    • Our Vision
    • Leadership Team
  • OUR RESEARCH
    • Our Approach
    • Publications
    • Conferences
  • PROGRAMS
    • Pipeline
    • VIS649 Sibeprenlimab
    • VIS171
    • VIS513
  • FOR PATIENTS
    • Clinical Trials
    • IgA Nephropathy
  • CAREERS
    • Open Positions & Benefits
    • Our Culture
    • Co-op program
  • Contact

VIS410, A Broad-Spectrum Anti-Influenza A Monoclonal Antibody Neutralized Baloxovir Resistant Influenza A Virus In-Vitro

August 28, 2019 | International Society for Influenza and Respiratory Viruses (ISIRV) 'OPTIONS X' Conference
Narayan, et. al.

VIS410, A Broad-Spectrum Anti-Influenza A Monoclonal Antibody Neutralized Baloxovir Resistant Influenza A Virus In-Vitro

Kristin Narayan, Jeremy Jones, Scott Rich, Elena Govorkova, Susan Sloan, David Oldach

>SEE POSTER

© 2023 Visterra, Inc. Terms of usePrivacy PolicySite Design: Fassino/Design